Hcmed

Hcmedverified

6934.TWO

Price:

$68.1

Market Cap:

$2.23B

HCmed Innovations Co Ltd. provides platforms for inhalation therapy using mesh technology. Its products include Pulmogine and AdheResp. The firm offers comprehensive aerosol characterization analytical services to support the development and optimization of inhalation products. It also offers analytical support in compliance with Pharmacopoeia guidelines. The company was founded by Jason Cheng, Leon Tsai, Shaogi Huang and Simon Hsieh on October 06, 2014 and is headquartered in Taipei, Taiwan.

Industry

Biotechnology

IPO Date

2024-06-25

Stock Exchange

TWO

Ticker

6934.TWO

The ROE as of July 2025 (TTM) for Hcmed (6934.TWO) is -36.85%

According to Hcmed’s latest financial reports and current stock price. The company's current ROE is -36.85%. This represents a change of 21.06% compared to the average of -30.44% of the last 4 quarters.

Hcmed (6934.TWO) Historical ROE (quarterly & annually)

How has 6934.TWO ROE performed in the past?

The mean historical ROE of Hcmed over the last ten years is -22.23%. The current -36.85% ROE has changed 65.73% with respect to the historical average. Over the past ten years (40 quarters), 6934.TWO's ROE was at its highest in in the December 2022 quarter at 0%. The ROE was at its lowest in in the June 2023 quarter at -47.98%.

Quarterly (TTM)
Annual

Average

-22.23%

Median

-37.37%

Minimum

-79.46%

Maximum

42.23%

Hcmed (6934.TWO) ROE by Quarter and Year

Discovering the peaks and valleys of Hcmed ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual ROE = 42.23%

Minimum Annual Increase = -440.71%

Minimum Annual ROE = -79.46%

Quarterly (TTM)
Annual
YearROEChange
2024-37.37%-37.62%
2023-59.90%-24.61%
2022-79.46%-440.71%
202123.32%-44.78%

Hcmed (6934.TWO) Average ROE

How has 6934.TWO ROE performed in the past?

The current ROE of Hcmed (6934.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-58.91%

5-year avg

-22.23%

10-year avg

-22.23%

Hcmed (6934.TWO) ROE vs. Peers

How is 6934.TWO’s ROE compared to its peers?

Hcmed’s ROE is

CompanyROEMarket cap

Build a custom stock screener for Hcmed (6934.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hcmed using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hcmed (6934.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hcmed or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Hcmed's ROE?

How is the ROE calculated for Hcmed (6934.TWO)?

What is the highest ROE for Hcmed (6934.TWO)?

What is the 3-year average ROE for Hcmed (6934.TWO)?

What is the 5-year average ROE for Hcmed (6934.TWO)?

How does the current ROE for Hcmed (6934.TWO) compare to its historical average?